Uremia
30
2
2
16
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 30 trials
100.0%
+13.5% vs benchmark
27%
8 trials in Phase 3/4
6%
1 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (30)
Dysregulated Urea-synthesis at Terminal Uremia
Evaluation of the Efficacy of Laser Acupuncture on Uremic Pruritus
Impact of Intestinal Microbiota on Uremic Toxins Productions
Dynamic Breath VOC Profiling as a Non-invasive Tool to Assess Hemodialysis Adequacy
Timing of Renal Replacement Therapy in the Critically Ill Patients
Independent Effects of Visceral Adipose Volume and Density on Patient Survival in Peritoneal Dialysis
BCD to Measure the ED95 of Remimazolam-Assisted Sedation in Arteriovenous Fistula Creation Surgery
Multi-center Clinical Study on Hemoperfusion of KHA80
A Comparative Study of Two Kinds of Hemodialysis Filters
Gabapentin Versus Loratadine in Uremic Pruritus
Paxlovid in the Treatment of COVID-19 Patients With Uremia
12 Weeks of Hemodialysis With Medium Cut-Off Filter Compared to Hemodiafiltration With Standard High-flux Filter.
A Clinical Trial of IntensiVE Dialysis
Reduction Ratio and Clearance During Hemodialysis With MCO-filter Compared to HDF With Standard High-flux Filter
Long-term Follow Up of Viral Hepatitis in Uremic Patients in Taiwan
Uremic Hyperhomocysteinemia -A Folate Trial for Possible Prevention of Cardiovascular Events
Probing the Dry Weight by Bioimpedance: The Resistance Stabilization Test
Effect of SVF Derived MSC in DCD Renal Transplantation
L-Cysteine in Peritoneal Dialysis
Probing the Dry Weight (DW) by Bioimpedance (BIA): Which is the Gold Standard Between Clinical DW and BIA DW?